StockNews.com assumed coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research report sent to investors on Thursday morning. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Lipocine stock opened at $4.30 on Thursday. Lipocine has a fifty-two week low of $3.30 and a fifty-two week […]
StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note released on Wednesday. The firm issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Up 4.4 % Shares of NASDAQ:LPCN opened at $4.50 on Wednesday. The company has a market capitalization of $23.40 million, a PE ratio […]
StockNews.com started coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a report issued on Wednesday. The firm set a “buy” rating on the specialty pharmaceutical company’s stock. Lipocine Stock Down 6.9 % Shares of Lipocine stock opened at $4.31 on Wednesday. The firm has a market cap of $22.41 million, a P/E ratio […]
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a research note issued to investors on Tuesday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Trading Up 1.6 % LPCN opened at $5.21 on Tuesday. The stock’s fifty day simple moving average is $4.92 and its 200 […]
StockNews.com initiated coverage on shares of Lipocine (NASDAQ:LPCN – Get Rating) in a report published on Monday. The brokerage issued a buy rating on the specialty pharmaceutical company’s stock. Lipocine Stock Performance Shares of NASDAQ LPCN opened at $3.67 on Monday. Lipocine has a fifty-two week low of $3.30 and a fifty-two week high of […]